S. Adachi

发表

A phase I/II study of docetaxel and gemcitabine combination for chemotherapy-resistant ovarian cancer.

H. Tsubamoto, Y. Itani, T. Tabata, 2009, Anticancer research.

Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma.

R. Ramlau, A. Santoro, J. Jassem, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Establishment and Characterization of a Subline Predisposed to Pulmonary Metastasis from a Human Gestational Choriocarcinoma Cell Line in Nude Mice

S. Takeuchi, H. Takahashi, S. Adachi, 1989, Acta obstetricia et gynecologica Scandinavica.

Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: a phase I/II study in Japanese patients.

N. Saijo, Y. Ichinose, M. Fukuoka, 2008, Japanese journal of clinical oncology.

Single-Agent Pemetrexed for Chemonaïve and Pretreated Patients with Malignant Pleural Mesothelioma: Results of an International Expanded Access Program

R. Labianca, R. V. van Klaveren, G. Scagliotti, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Bone morphogenetic protein-2 and type IV collagen expression in psammoma body forming ovarian cancer.

K. Bessho, T. Matsuyama, Y. Uemura, 2001, Anticancer research.

A phase I study of pemetrexed (LY231514) supplemented with folate and vitamin B12 in Japanese patients with solid tumours

M. Fukuoka, S. Kudoh, N. Yamamoto, 2006, British Journal of Cancer.

A pilot study of CPT-11 and cisplatin for ovarian clear cell adenocarcinoma.

H. Shibahara, K. Koyama, Y. Tsuji, 1999, Japanese journal of clinical oncology.

[Chemotherapy for advanced or metastatic pancreatic cancer: analysis of 43 randomized trials in 3 decades (1974-2002)].

M. Fung, T. Morizane, S. Adachi, 2003, Gan to kagaku ryoho. Cancer & chemotherapy.

Cytotoxic antibody against trophoblast and lymphocytes present in pregnancy with intrauterine fetal growth retardation and its relation to anti-phospholipid antibody.

I. Hasegawa, K. Takakuwa, S. Adachi, 1990, Journal of reproductive immunology.

Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.

H. Oku, K. Koyama, H. Tsubamoto, 2001, International journal of clinical pharmacology research.

Successful pregnancy in an infertile patient with conservatively treated endometrial adenocarcinoma after transfer of embryos obtained by intracytoplasmic sperm injection.

H. Shibahara, K. Koyama, S. Adachi, 1999, Human reproduction.

6560 POSTER Prognostic factors affecting survival on pretreated patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) – Subgroup analysis in a randomized Ph II study of pemetrexed 500 mg/m2 and 1000 mg/m2

N. Saijo, Y. Nishiwaki, M. Fukuoka, 2007 .

A randomized phase II study of 500 mg/m2 and 1,000 mg/m2 of pemetrexed in patients (pts) with locally advanced or metastatic non-small cell lung cancer (NSCLC) who had prior chemotherapy

N. Saijo, Y. Ichinose, Y. Nishiwaki, 2007 .

The regulation of oxytocin receptor expression in human myometrial monolayer culture.

S. Adachi, M. Oku, S. Adachi, 1995, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.

Combination chemotherapy using intravenous nedaplatin (254-S) and intraarterial cisplatin (CDDP) with transcatheter arterial embolization (TAE) for a patient with uterine cervical cancer: a case report.

K. Koyama, S. Adachi, T. Ogasawara, 1997, Japanese journal of clinical oncology.

Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.

Y. Uemura, S. Adachi, A. Tsubura, 2000, Anticancer research.

Expression of HLA-DR molecules in human gestational choriocarcinoma cell lines and malignant cell lines.

S. Takeuchi, H. Takahashi, S. Adachi, 1987, Placenta.

Maintenance pemetrexed plus best supportive care (BSC) versus placebo plus BSC: A phase III study

Yi-long Wu, M. Krzakowski, T. Ciuleanu, 2008 .

C5-03: Open-label study of pemetrexed alone or in combination with a platinum for previously treated patients (pts) with malignant pleural mesothelioma (MPM): Outcomes from the International Expanded Access Program (EAP)

M. Marangolo, U. Gatzemeier, P. Taylor, 2007 .

Efficacy and Safety of Two Doses of Pemetrexed Supplemented with Folic Acid and Vitamin B12 in Previously Treated Patients with Non-Small Cell Lung Cancer

N. Saijo, Y. Ichinose, Y. Nishiwaki, 2008, Clinical Cancer Research.

Efficacy and Safety ofTwo Doses of Pemetrexed Supplemented with Folic Acid andVitamin B 12 in PreviouslyTreated Patients with Non-Small Cell Lung Cancer

N. Saijo, Y. Ichinose, Y. Nishiwaki, 2008 .

[Isolation of cisplatin-resistant subline from human ovarian cancer cell line and analysis of its cell-biological characteristics].

S. Adachi, K. Kanazawa, Y. Misawa, 1989, Nihon Sanka Fujinka Gakkai zasshi.

[The effect of oxytocin on production of free fatty acid in primary human uterine myometrial cell culture].

T. Otsuki, E. Fujii, M. Ichijo, 1993, Nihon Sanka Fujinka Gakkai zasshi.

Complications associated with CDDP intraperitoneal chemotherapy.

Y. Itani, K. Ito, H. Hisanaga, 2010, Asia-Oceania journal of obstetrics and gynaecology.

A pilot study of paclitaxel and carboplatin for recurrent ovarian cancer.

K. Ito, M. Ozawa, S. Adachi, 2001, Oncology Report.

[Antitumor effect of UFT on human ovarian cancer grafted to nude mice and 5-FU concentration in tumor and normal tissues].

S. Takeuchi, M. Ishida, S. Adachi, 1988, Gan to kagaku ryoho. Cancer & chemotherapy.

[Effects of steroid hormones on change in [Ca2+]i following oxytocin stimulation in cultured human myometrial cells, and on myometrial oxytocin receptor].

T. Otsuki, E. Fujii, M. Ichijo, 1993, Nihon Sanka Fujinka Gakkai zasshi.